VEGFA and coronary artery disorder: So far, efficacy of VEGF delivery strategies in PAD and CAD clinical trials is still below expectation, and systems biology studies that can quantitatively model multiscale cytokine interaction and angiogenesis will likely advance future drug designs for ischemic vascular disease [89].